1. MAPK/ERK Pathway
  2. MAP3K
  3. ZAK-IN-1

ZAK-IN-1 是一种口服有效且选择性的 亮氨酸拉链和不育α基序激酶 ZAK 抑制剂,其 IC50 为 4 nM,KD 为 8 nM。ZAK-IN-1 对 403 种野生型激酶显示出优异的选择性。 ZAK-IN-1 能够阻断 p38/GATA-4 和 JNK/c-Jun 信号通路,并可显著抑制心肌肥大。ZAK-IN-1 可用于肥厚型心肌病 (HCM) 的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

ZAK-IN-1 Chemical Structure

ZAK-IN-1 Chemical Structure

CAS No. : 2362525-64-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

ZAK-IN-1 is an orally active and selective selective leucine-zipper and sterile‑α motif kinase (ZAK) inhibitor with IC50 of 4 nM and KD of 8 nM. ZAK-IN-1 exhibits excellent selectivity against a panel of 403 wild-type kinases. ZAK-IN-1 blocks p38/GATA-4 and JNK/c-Jun signaling and shows promising anti antihypertrophic cardiomyopathy (HCM) efficacy. ZAK-IN-1 can be used for the study of HCM[1].

体外研究
(In Vitro)

ZAK-IN-1 (Compound 6p) (0-10 μg/mL, 24 h) 在 H9c2 细胞中通过阻断 p38/GATA-4 和 JNK/c-Jun 信号通路,有效抑制由 ZAKα 过表达引发的心肌细胞肥大。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: H9c2 cells
Concentration: 0, 2.5, 5, 10 μg/mL
Incubation Time: 24 h
Result: Dose dependently inhibited the phosphorylated ZAKα but had no detectable impact on the ZAKα expression level.
Blocked the cardiac hypertrophy induced by AngII and Doxycycline (HY-N0565) .
Dose dependently decreased the expression of brain natriuretic peptide (BNP).
Suppressed the elevation of p-JNK and p-p38 and hypertrophic transcription factors p-GATA-4 and p-c-Jun.
药代动力学
(Parmacokinetics)
Species Dose Route Indicator value
Rat 10 mg/kg p.o. Cmax 16372.2 μg/L
Rat 2.5 mg/kg i.v. AUC0-∞ 27866.1 μg/L·h
Rat 10 mg/kg p.o. T1/2 1.7 h
Rat 2.5 mg/kg i.v. AUC0-t 27424.4 μg/L·h
Rat 10 mg/kg p.o. AUC0-t 71572.6 μg/L·h
Rat 2.5 mg/kg i.v. T1/2 1.6 h
Rat 10 mg/kg p.o. AUC0-∞ 71790.9 μg/L·h
Rat 2.5 mg/kg i.v. Cmax 34151.6 μg/L
Rat 10 mg/kg p.o. Bioavailability 65.3 %
Rat 2.5 mg/kg i.v. CL 91.9 L/h/kg
体内研究
(In Vivo)

ZAK-IN-1 (Compound 6p) (0-10 mg/kg, p.o., 每日 1 次共 8 周) 在自发性高血压大鼠模型中展现了良好的抗心肌肥大效果[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Spontaneous hypertensive rats (SHR) model established by SD male rats (180-220 g) [1]
Dosage: 0, 2.5, and 10 mg/kg
Administration: Oral administration (p.o.), once daily for 8 weeks
Result: Suppressed the whole heart and the left ventricle mass elevation and rescued the hypertrophic symptoms in a dose-dependent manner.
Suppressed the phosphorylation of ZAK down-stream signaling JNK, p38, c-Jun, p-GATA-4, and protein levels of hypertrophic markers BNP and ANP in a dose-dependent manner.
分子量

559.55

Formula

C27H19F2N7O3S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
ZAK-IN-1
目录号:
HY-128326
需求量: